Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma.

He Y, Wang Z, Liu C, Gong Z, Li Y, Lu T, Hu G

DOI: 10.2147/cmar.s191102
Published: 2019
Container: Cancer management and research
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/cmar.s191102,
  title = {Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma.},
  author = {He Y and Wang Z and Liu C and Gong Z and Li Y and Lu T and Hu G},
  year = {2019},
  journal = {Cancer management and research},
  doi = {10.2147/cmar.s191102},
  url = {https://doi.org/10.2147/cmar.s191102}
}

RIS

TY  - JOUR
TI  - Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma.
AU  - He Y
AU  - Wang Z
AU  - Liu C
AU  - Gong Z
AU  - Li Y
AU  - Lu T
AU  - Hu G
PY  - 2019
JO  - Cancer management and research
DO  - 10.2147/cmar.s191102
UR  - https://doi.org/10.2147/cmar.s191102
ER  -

APA

Y, H., Z, W., C, L., Z, G., Y, L., T, L., & G, H. (2019). Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma.. Cancer management and research. https://doi.org/10.2147/cmar.s191102

Source records

pubmed · retrieved 2026-09-24T21:34:56.103Z